Point-of-Care Molecular Diagnostics Market by Product & Service (Assays, Instruments, Software), Technology (RT-PCR, INAAT), Sample Type (Blood, Urine), Application (STD, HAI, Hepatitis, Cancer), and End User (Hospitals, Clinics) - Global Forecast to 2030

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered & Regional Scope
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Key Stakeholders
1.5 Summary of Changes

2.1 Research Data
2.2 Research Approach
2.2.1 Secondary Data
2.2.1.1 Key Secondary Sources
2.2.1.2 Key Data from Secondary Sources
2.2.2 Primary Data
2.2.2.1 Primary Sources
2.2.2.2 Key Data from Primary Sources
2.2.2.3 Key Industry Insights
2.2.2.4 Breakdown of Primary Interviews
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.1.1 Approach 1: Company Revenue Estimation Approach
2.3.1.2 Approach 2: Presentations of Companies and Primary Interviews
2.3.1.3 Growth Forecast
2.3.1.4 CAGR Projections
2.3.2 Top-Down Approach
2.4 Market Breakdown & Data Triangulation
2.5 Market Share Assessment
2.6 Research Assumptions
2.6.1 Parametric Assumptions
2.7 Research Limitations
2.8 Risk Assessment

4.1 Point of Care Molecular Diagnostics Market Overview
4.2 Point of Care Molecular Diagnostics Market, by Product & Service, 2025 vs. 2030 (USD Million)
4.3 Point of Care Molecular Diagnostics Market, by Technology, 2025 vs. 2030 (USD Million)
4.4 Point of Care Molecular Diagnostics Market, by Sample Type, 2025 vs. 2030 (USD Million)
4.5 Point of Care Molecular Diagnostics Market, by Application, 2025 vs. 2030 (USD Million)
4.6 Point of Care Molecular Diagnostics Market, by End-user, 2025 vs. 2030 (USD Million)
4.7 Point of Care Molecular Diagnostics Market: Geographic Growth Opportunities

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Prevalence of Infectious Diseases and Cancer
5.2.1.2 Increasing Focus on Decentralized Diagnostics and Subsequent Rise in R&D Funding
5.2.1.3 Growing Awareness Associated with Early Disease Diagnosis
5.2.1.4 Increasing Use of Poc Diagnostic Tests
5.2.2 Restraints
5.2.2.1 Unfavorable Reimbursements
5.2.2.2 High Capital Investments and Low Cost-Benefit Ratio
5.2.3 Opportunities
5.2.3.1 Growth Opportunities in Emerging Economies
5.2.4 Challenges
5.2.4.1 Stringent Regulatory Guidelines That Impact Product Commercialization
5.2.4.2 Introduction of Alternative Technologies
5.3 Pricing Analysis
5.3.1 Average Price Trend of Point of Care Molecular Diagnostic Products, 2023-2025
5.3.2 Average Price Trend of Point of Care Molecular Diagnostic Assays & Kits, by Key Player, 2023-2025
5.3.3 Average Selling Price Trend of Point of Care Molecular Diagnostic Products, by Region, 2023-2025
5.4 Patent Analysis
5.4.1 List of Key Patents
5.5 Value Chain Analysis
5.6 Supply Chain Analysis
5.7 Trade Analysis
5.7.1 Trade Analysis for Diagnostic & Laboratory Reagents
5.7.2 Import Data (HS Code 3822)
5.7.3 Export Data (HS Code 3822)
5.8 Ecosystem Analysis
5.8.1 Point of Care Molecular Diagnostics Market: Role in Ecosystem
5.9 Porter's Five Forces Analysis
5.9.1 Threat of New Entrants
5.9.2 Bargaining Power of Suppliers
5.9.3 Threat of Substitutes
5.9.4 Bargaining Power of Buyers
5.9.5 Intensity of Competitive Rivalry
5.10 Regulatory Landscape
5.10.1 Regulatory Framework
5.10.1.1 North America
5.10.1.1.1 US
5.10.1.1.2 Canada
5.10.1.2 Europe
5.10.1.2.1 Germany
5.10.1.2.2 UK
5.10.1.2.3 France
5.10.1.2.4 Italy
5.10.1.3 Asia-Pacific
5.10.1.3.1 China
5.10.1.3.2 Japan
5.10.1.3.3 India
5.10.1.4 Latin America
5.10.1.4.1 Brazil
5.10.1.4.2 Mexico
5.10.1.5 Middle East
5.10.1.5.1 Africa
5.10.2 Regulatory Bodies, Government Agencies, and Other Organizations
5.11 Technology Analysis
5.11.1 Key Technologies
5.11.1.1 Rt-Pcr
5.11.2 Complementary Technologies
5.11.2.1 Inaat (Isolated Nucleic Acid Amplification Technology)
5.11.3 Adjacent Technologies
5.11.3.1 Crispr (Clustered Regularly Interspaced Short Palindromic Repeats)
5.12 Key Conferences & Events, 2025-2026
5.13 Trends/Disruptions Impacting Customers’ Businesses
5.14 Key Stakeholders & Buying Criteria
5.14.1 Key Stakeholders in Buying Process
5.14.2 Buying Criteria
5.15 Investment & Funding Scenario
5.16 Case Study Analysis
5.16.1 Case Study 1: Rapid Point of Care Pcr Testing Streamlines Emergency Care for Hospital in Germany
5.16.2 Case Study 2: Implementation of Rapid Pcr Testing to Improve Norovirus Diagnosis & Bed Management
5.16.3 Case Study 3: Using Molecular Diagnostics to Identify Atypical Respiratory Infection
5.17 Impact of AI/Generative AI in Point of Care Molecular Diagnostics Market
5.17.1 Introduction
5.17.2 Market Potential of AI
5.17.3 AI-Use Cases
5.17.4 Implementation of AI, by Key Company & Use Case
5.17.5 Future of AI in Point of Care Molecular Diagnostics Market
5.18 Trump Tariff Impact on Point of Care Molecular Diagnostics Market
5.18.1 Introduction
5.18.2 Key Tariff Rates
5.18.3 Price Impact Analysis
5.18.4 Impact on Country/Region
5.18.4.1 North America
5.18.4.2 Europe
5.18.4.3 Asia-Pacific
5.18.5 Impact on End-use Industries
5.18.5.1 Physicians’ Offices/Clinics
5.18.5.2 Hospitals
5.18.5.3 Research Institutes

6.1 Introduction
6.2 Assays & Kits
6.2.1 Recurrent Purchase to Propel Market
6.3 Instruments & Analyzers
6.3.1 Increasing Adoption of Advanced Poc Technologies to Drive Market
6.4 Software & Services
6.4.1 Utilization of Solutions for Enhanced User Experience to Support Market Growth

7.1 Introduction
7.2 Rt-Pcr
7.2.1 High Sensitivity and Specificity to Boost Demand
7.3 Inaat
7.3.1 Cost-Benefits and Rapid Amplification Abilities to Propel Market
7.4 Other Technologies

8.1 Introduction
8.2 Blood Samples
8.2.1 Ability to Support Rapid Detection for Several Diseases to Propel Market
8.3 Urine Samples
8.3.1 Non-Invasive Nature and Detection of Low Biomarker Concentration to Boost Demand
8.4 Other Sample Types

9.1 Introduction
9.2 Respiratory Diseases
9.2.1 Rising Incidence of Influenza and Rsv to Drive Market
9.3 Sexually Transmitted Diseases
9.3.1 Rising Prevalence of Hpv and HIV to Drive Market
9.4 Hospital-Acquired Infections
9.4.1 Growing Focus on Targeted Clinical Therapy for Reduction in Hais to Fuel Market
9.5 Cancer
9.5.1 Increasing Preference for Oncology Therapeutics to Drive Market
9.6 Hepatitis
9.6.1 Increasing Prevalence Among High-Risk Subgroup Populations to Propel Market
9.7 Gastrointestinal Disorders
9.7.1 Rising Incidence of Ibs to Support Market Growth
9.8 Other Applications

10.1 Introduction
10.2 Hospitals
10.2.1 Capability to Purchase Advanced Diagnostic Equipment and Ability to Support High Patient Footfall to Propel Market
10.2.1.1 Sepsis
10.2.1.1.1 Rising Requirement for Rapid Diagnosis & Treatment to Fuel Uptake
10.2.1.2 Gastroenteritis
10.2.1.2.1 Increasing Admissions to Critical Care Units and Rising Focus on Molecular Tools for Diagnosis to Fuel Uptake
10.2.1.3 Meningoencephalitis
10.2.1.3.1 Initialization of Targeted Treatment due to High Mortality Risk to Fuel Market
10.2.1.4 Other Diseases
10.3 Physicians’ Offices/Clinics
10.3.1 Rapid Results and Individualized Care to Fuel Market
10.4 Research Institutes
10.4.1 Increasing Focus on Genomics & Proteomics Research to Boost Demand
10.5 Other End-users

11.1 Introduction
11.2 North America
11.2.1 North America: Macroeconomic Outlook
11.2.2 US
11.2.2.1 High Healthcare Expenditure for Advanced Molecular Diagnostic Technologies to Drive Market
11.2.3 Canada
11.2.3.1 Favorable Government Initiatives for Early Disease Diagnosis Awareness to Fuel Market
11.3 Europe
11.3.1 Europe: Macroeconomic Outlook
11.3.2 Germany
11.3.2.1 Universal Healthcare Coverage and Favorable Growth for Decentralized Care Settings to Fuel Market
11.3.3 UK
11.3.3.1 Rising Prevalence of Stis to Boost Demand
11.3.4 France
11.3.4.1 High Disease Burden of Infectious Diseases and Cancer to Drive Market
11.3.5 Italy
11.3.5.1 Rising Demand for High-Precision Diagnostic Tools to Support Market Growth
11.3.6 Spain
11.3.6.1 Rising Incidence of Respiratory Illnesses and HIV to Boost Demand
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Asia-Pacific: Macroeconomic Outlook
11.4.2 China
11.4.2.1 Increasing Incidence of Influenza and Epidemics to Propel Market
11.4.3 Japan
11.4.3.1 Growing Access to Advanced & Affordable Healthcare Services to Fuel Market
11.4.4 India
11.4.4.1 Expanding Healthcare Access and Increasing Prevalence of HIV to Propel Market
11.4.5 Rest of Asia-Pacific
11.5 Latin America
11.5.1 Latin America: Macroeconomic Outlook
11.5.2 Brazil
11.5.2.1 High Incidence of Hepatitis to Support Market Uptake
11.5.3 Mexico
11.5.3.1 Rising Cases of Tb and Hais to Fuel Market
11.5.4 Rest of Latin America
11.6 Middle East & Africa
11.6.1 Middle East & Africa: Macroeconomic Outlook
11.6.2 Kingdom of Saudi Arabia (KSA)
11.6.2.1 Improvements in Healthcare Infrastructure to Drive Market
11.6.3 United Arab Emirates (UAE)
11.6.3.1 Rising Technological Advancements in Molecular Diagnostics to Fuel Market
11.6.4 Rest of Middle East & Africa

12.1 Introduction
12.2 Key Player Strategies/Right to Win
12.2.1 Overview of Strategies Deployed by Players in Point of Care Molecular Diagnostics Market
12.3 Revenue Share Analysis, 2022-2024
12.4 Market Share Analysis, 2024
12.5 Company Evaluation Matrix: Key Players, 2024
12.5.1 Stars
12.5.2 Emerging Leaders
12.5.3 Pervasive Players
12.5.4 Participants
12.5.5 Company Footprint: Key Players, 2024
12.5.5.1 Company Footprint
12.5.5.2 Region Footprint
12.5.5.3 Product & Service Footprint
12.5.5.4 Technology Footprint
12.5.5.5 Application Footprint
12.6 Company Evaluation Matrix: Startups/SMEs, 2024
12.6.1 Progressive Companies
12.6.2 Responsive Companies
12.6.3 Dynamic Companies
12.6.4 Starting Blocks
12.6.5 Competitive Benchmarking: Startups/SMEs, 2024
12.6.5.1 Detailed List of Key Startups/SMEs
12.6.5.2 Competitive Benchmarking of Key Emerging Players/Startups (1/2)
12.6.5.3 Competitive Benchmarking of Key Startups/SMEs (2/2)
12.7 Company Valuation & Financial Metrics
12.7.1 Financial Metrics
12.7.2 Company Valuation
12.8 Brand/Product Comparison
12.8.1 Brand/Product Comparative Analysis
12.9 Competitive Scenario
12.9.1 Product/Service Launches & Approvals
12.9.2 Deals
12.9.3 Expansions

13.1 Key Players
13.1.1 Danaher Corporation
13.1.1.1 Business Overview
13.1.1.2 Products/Services Offered
13.1.1.3 Recent Developments
13.1.1.3.1 Product/Service Launches & Approvals
13.1.1.3.2 Deals
13.1.1.3.3 Expansions
13.1.1.4 Analyst's View
13.1.1.4.1 Key Strengths
13.1.1.4.2 Strategic Choices
13.1.1.4.3 Weaknesses & Competitive Threats
13.1.2 Biomérieux
13.1.2.1 Business Overview
13.1.2.2 Products/Services Offered
13.1.2.3 Recent Developments
13.1.2.3.1 Product/Service Launches & Approvals
13.1.2.3.2 Deals
13.1.2.4 Analyst's View
13.1.2.4.1 Key Strengths
13.1.2.4.2 Strategic Choices
13.1.2.4.3 Weaknesses & Competitive Threats
13.1.3 F. Hoffmann-La Roche Ltd.
13.1.3.1 Business Overview
13.1.3.2 Products/Services Offered
13.1.3.3 Recent Developments
13.1.3.3.1 Products/Services Launches & Approvals
13.1.3.3.2 Deals
13.1.3.3.3 Expansions
13.1.3.4 Analyst's View
13.1.3.4.1 Key Strengths
13.1.3.4.2 Strategic Choices
13.1.3.4.3 Weaknesses & Competitive Threats
13.1.4 Abbott
13.1.4.1 Business Overview
13.1.4.2 Products/Services Offered
13.1.4.3 Recent Developments
13.1.4.3.1 Deals
13.1.4.4 Analyst's View
13.1.4.4.1 Key Strengths
13.1.4.4.2 Strategic Choices
13.1.4.4.3 Weaknesses & Competitive Threats
13.1.5 Qiagen N.V.
13.1.5.1 Business Overview
13.1.5.2 Products/Services Offered
13.1.5.3 Recent Developments
13.1.5.3.1 Product Launches & Approvals
13.1.5.3.2 Deals
13.1.5.3.3 Expansions
13.1.5.4 Analyst's View
13.1.5.4.1 Key Strengths
13.1.5.4.2 Strategic Choices
13.1.5.4.3 Weaknesses & Competitive Threats
13.1.6 Quidelortho Corporation
13.1.6.1 Business Overview
13.1.6.2 Products/Services Offered
13.1.6.3 Recent Developments
13.1.6.3.1 Product/Service Launches & Approvals
13.1.6.3.2 Deals
13.1.6.3.3 Expansions
13.1.7 Co-Diagnostics, Inc.
13.1.7.1 Business Overview
13.1.7.2 Products/Services Offered
13.1.7.3 Recent Developments
13.1.7.3.1 Deals
13.1.7.3.2 Expansions
13.1.8 Biocartis
13.1.8.1 Business Overview
13.1.8.2 Products/Services Offered
13.1.8.3 Recent Developments
13.1.8.3.1 Product/Service Launches & Approvals
13.1.8.3.2 Deals
13.1.9 Sd Biosensor, Inc.
13.1.9.1 Business Overview
13.1.9.2 Products/Services Offered
13.1.9.3 Recent Developments
13.1.9.3.1 Product/Service Launches
13.1.9.3.2 Deals
13.1.9.3.3 Other Developments
13.1.10 Genedrive PLC
13.1.10.1 Business Overview
13.1.10.2 Products/Services Offered
13.2 Other Players
13.2.1 Binx Health, Inc.
13.2.2 Molbio Diagnostics Limited
13.2.3 Opgen, Inc.
13.2.4 Genomadix
13.2.5 Visby Medical, Inc.
13.2.6 Quantumdx Group Ltd.
13.2.7 Detectachem
13.2.8 Labsystems Diagnostics Oy
13.2.9 Akonni Biosystems, Inc.
13.2.10 Ubiquitome Limited
13.2.11 Credo Diagnostics Biomedical Pte. Ltd.
13.2.12 Nuclein, LLC
13.2.13 Genes2Me
13.2.14 Axxin
13.2.15 Huwel Lifesciences

14.1 Discussion Guide
14.2 Knowledgestore: The Subscription Portal
14.3 Customization Options

Table 1 Point of Care Molecular Diagnostics Market: Inclusions & Exclusions
Table 2 Point of Care Molecular Diagnostics Market: Key Data from Primary Sources
Table 3 Point of Care Molecular Diagnostics Market: Risk Assessment Analysis
Table 4 Regional HIV Data, 2024
Table 5 Average Selling Pricing Trend of Point of Care Molecular Diagnostic Products, 2023-2025
Table 6 Average Selling Price Trend of Point of Care Molecular Diagnostic Assays & Kits, by Key Player, 2023-2025
Table 7 Average Selling Price Trend of Point of Care Molecular Diagnostic Products, by Region, 2023-2025
Table 8 Point of Care Molecular Diagnostics Market: List of Major Patents
Table 9 Import Data for Diagnostic and Laboratory Reagents (HS Code 3822), by Country, 2020-2024 (USD Million)
Table 10 Export Data for Diagnostic and Laboratory Reagents (HS Code 3822), by Country, 2020-2024 (USD Million)
Table 11 Point of Care Molecular Diagnostics Market: Role in Ecosystem
Table 12 Point of Care Molecular Diagnostics Market: Porter's Five Forces Analysis
Table 13 Classification of Ivd Devices in Europe
Table 14 Time, Cost, and Complexity of Registration Process in Japan
Table 17 Asia-Pacific: Key Regulatory Bodies, Government Agencies, and Other Organizations
Table 20 Point of Care Molecular Diagnostics Market: Detailed List of Key Conferences & Events, January 2025-December 2026
Table 21 Influence of Stakeholders on Buying Process of Point of Care Molecular Diagnostic Products (%)
Table 22 Key Buying Criteria for Point of Care Molecular Diagnostic Products
Table 23 Implementation of AI, by Key Company & Use Case
Table 24 US-Adjusted Reciprocal Tariff Rates
Table 25 Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 26 Key Assays & Kits Currently Available
Table 27 Point of Care Molecular Diagnostics Market for Assays & Kits, by Region, 2023-2030 (USD Million)
Table 28 North America: Point of Care Molecular Diagnostics Market for Assays & Kits, by Country, 2023-2030 (USD Million)
Table 29 Europe: Point of Care Molecular Diagnostics Market for Assays & Kits, by Country, 2023-2030 (USD Million)
Table 30 Asia-Pacific: Point of Care Molecular Diagnostics Market for Assays & Kits, by Country, 2023-2030 (USD Million)
Table 31 Latin America: Point of Care Molecular Diagnostics Market for Assays & Kits, by Country, 2023-2030 (USD Million)
Table 32 Middle East & Africa: Point of Care Molecular Diagnostics Market for Assays & Kits, by Country, 2023-2030 (USD Million)
Table 33 Key Instruments & Analyzers Currently Available
Table 34 Point of Care Molecular Diagnostics Market for Instruments & Analyzers, by Region, 2023-2030 (USD Million)
Table 35 North America: Point of Care Molecular Diagnostics Market for Instruments & Analyzers, by Country, 2023-2030 (USD Million)
Table 36 Europe: Point of Care Molecular Diagnostics Market for Instruments & Analyzers, by Country, 2023-2030 (USD Million)
Table 37 Asia-Pacific: Point of Care Molecular Diagnostics Market for Instruments & Analyzers, by Country, 2023-2030 (USD Million)
Table 38 Latin America: Point of Care Molecular Diagnostics Market for Instruments & Analyzers, by Country, 2023-2030 (USD Million)
Table 39 Middle East & Africa: Point of Care Molecular Diagnostics Market for Instruments & Analyzers, by Country, 2023-2030 (USD Million)
Table 40 Key Software & Services Currently Available
Table 41 Point of Care Molecular Diagnostics Market for Software & Services, by Region, 2023-2030 (USD Million)
Table 42 North America: Point of Care Molecular Diagnostics Market for Software & Services, by Country, 2023-2030 (USD Million)
Table 43 Europe: Point of Care Molecular Diagnostics Market for Software & Services, by Country, 2023-2030 (USD Million)
Table 44 Asia-Pacific: Point of Care Molecular Diagnostics Market for Software & Services, by Country, 2023-2030 (USD Million)
Table 45 Latin America: Point of Care Molecular Diagnostics Market for Software & Services, by Country, 2023-2030 (USD Million)
Table 46 Middle East & Africa: Point of Care Molecular Diagnostics Market for Software & Services, by Country, 2023-2030 (USD Million)
Table 47 Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 48 Key Rt-Pcr-based Products Currently Available
Table 49 Point of Care Molecular Diagnostics Market for Rt-Pcr, by Region, 2023-2030 (USD Million)
Table 50 North America: Point of Care Molecular Diagnostics Market for Rt-Pcr, by Country, 2023-2030 (USD Million)
Table 51 Europe: Point of Care Molecular Diagnostics Market for Rt-Pcr, by Country, 2023-2030 (USD Million)
Table 52 Asia-Pacific: Point of Care Molecular Diagnostics Market for Rt-Pcr, by Country, 2023-2030 (USD Million)
Table 53 Latin America: Point of Care Molecular Diagnostics Market for Rt-Pcr, by Country, 2023-2030 (USD Million)
Table 54 Middle East & Africa: Point of Care Molecular Diagnostics Market for Rt-Pcr, by Country, 2023-2030 (USD Million)
Table 55 Key Inaat-based Products Currently Available
Table 56 Point of Care Molecular Diagnostics Market for Inaat, by Region, 2023-2030 (USD Million)
Table 57 North America: Point of Care Molecular Diagnostics Market for Inaat, by Country, 2023-2030 (USD Million)
Table 58 Europe: Point of Care Molecular Diagnostics Market for Inaat, by Country, 2023-2030 (USD Million)
Table 59 Asia-Pacific: Point of Care Molecular Diagnostics Market for Inaat, by Country, 2023-2030 (USD Million)
Table 60 Latin America: Point of Care Molecular Diagnostics Market for Inaat, by Country, 2023-2030 (USD Million)
Table 61 Middle East & Africa: Point of Care Molecular Diagnostics Market for Inaat, by Country, 2023-2030 (USD Million)
Table 62 Point of Care Molecular Diagnostics Market for Other Technologies, by Region, 2023-2030 (USD Million)
Table 63 North America: Point of Care Molecular Diagnostics Market for Other Technologies, by Country, 2023-2030 (USD Million)
Table 64 Europe: Point of Care Molecular Diagnostics Market for Other Technologies, by Country, 2023-2030 (USD Million)
Table 65 Asia-Pacific: Point of Care Molecular Diagnostics Market for Other Technologies, by Country, 2023-2030 (USD Million)
Table 66 Latin America: Point of Care Molecular Diagnostics Market for Other Technologies, by Country, 2023-2030 (USD Million)
Table 67 Middle East & Africa: Point of Care Molecular Diagnostics Market for Other Technologies, by Country, 2023-2030 (USD Million)
Table 68 Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 69 Key Blood Sample Type-based Products Currently Available
Table 70 Point of Care Molecular Diagnostics Market for Blood Samples, by Region, 2023-2030 (USD Million)
Table 71 North America: Point of Care Molecular Diagnostics Market for Blood Samples, by Country, 2023-2030 (USD Million)
Table 72 Europe: Point of Care Molecular Diagnostics Market for Blood Samples, by Country, 2023-2030 (USD Million)
Table 73 Asia-Pacific: Point of Care Molecular Diagnostics Market for Blood Samples, by Country, 2023-2030 (USD Million)
Table 74 Latin America: Point of Care Molecular Diagnostics Market for Blood Samples, by Country, 2023-2030 (USD Million)
Table 75 Middle East & Africa: Point of Care Molecular Diagnostics Market for Blood Samples, by Country, 2023-2030 (USD Million)
Table 76 Key Urine Sample-based Products Currently Available
Table 77 Point of Care Molecular Diagnostics Market for Urine Samples, by Region, 2023-2030 (USD Million)
Table 78 North America: Point of Care Molecular Diagnostics Market for Urine Samples, by Country, 2023-2030 (USD Million)
Table 79 Europe: Point of Care Molecular Diagnostics Market for Urine Samples, by Country, 2023-2030 (USD Million)
Table 80 Asia-Pacific: Point of Care Molecular Diagnostics Market for Urine Samples, by Country, 2023-2030 (USD Million)
Table 81 Latin America: Point of Care Molecular Diagnostics Market for Urine Samples, by Country, 2023-2030 (USD Million)
Table 82 Middle East & Africa: Point of Care Molecular Diagnostics Market for Urine Samples, by Country, 2023-2030 (USD Million)
Table 83 Key Other Sample Type-based Products Currently Available
Table 84 Point of Care Molecular Diagnostics Market for Other Sample Types, by Region, 2023-2030 (USD Million)
Table 85 North America: Point of Care Molecular Diagnostics Market for Other Sample Types, by Country, 2023-2030 (USD Million)
Table 86 Europe: Point of Care Molecular Diagnostics Market for Other Sample Types, by Country, 2023-2030 (USD Million)
Table 87 Asia-Pacific: Point of Care Molecular Diagnostics Market for Other Sample Types, by Country, 2023-2030 (USD Million)
Table 88 Latin America: Point of Care Molecular Diagnostics Market for Other Sample Types, by Country, 2023-2030 (USD Million)
Table 89 Middle East & Africa: Point of Care Molecular Diagnostics Market for Other Sample Types, by Country, 2023-2030 (USD Million)
Table 90 Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 91 Key Poc Molecular Diagnostic Products for Respiratory Diseases Currently Available
Table 92 Point of Care Molecular Diagnostics Market for Respiratory Diseases, by Region, 2023-2030 (USD Million)
Table 93 North America: Point of Care Molecular Diagnostics Market for Respiratory Diseases, by Country, 2023-2030 (USD Million)
Table 94 Europe: Point of Care Molecular Diagnostics Market for Respiratory Diseases, by Country, 2023-2030 (USD Million)
Table 95 Asia-Pacific: Point of Care Molecular Diagnostics Market for Respiratory Diseases, by Country, 2023-2030 (USD Million)
Table 96 Latin America: Point of Care Molecular Diagnostics Market for Respiratory Diseases, by Country, 2023-2030 (USD Million)
Table 97 Middle East & Africa: Point of Care Molecular Diagnostics Market for Respiratory Diseases, by Country, 2023-2030 (USD Million)
Table 98 Number of Newly Diagnosed Tuberculosis (Tb) Cases, 2023-2030 (In Millions)
Table 99 Key Poc Molecular Diagnostic Products for Sexually Transmitted Diseases Currently Available
Table 100 Point of Care Molecular Diagnostics Market for Sexually Transmitted Diseases, by Region, 2023-2030 (USD Million)
Table 101 North America: Point of Care Molecular Diagnostics Market for Sexually Transmitted Diseases, by Country, 2023-2030 (USD Million)
Table 102 Europe: Point of Care Molecular Diagnostics Market for Sexually Transmitted Diseases, by Country, 2023-2030 (USD Million)
Table 103 Asia-Pacific: Point of Care Molecular Diagnostics Market for Sexually Transmitted Diseases, by Country, 2023-2030 (USD Million)
Table 104 Latin America: Point of Care Molecular Diagnostics Market for Sexually Transmitted Diseases, by Country, 2023-2030 (USD Million)
Table 105 Middle East & Africa: Point of Care Molecular Diagnostics Market for Sexually Transmitted Diseases, by Country, 2023-2030 (USD Million)
Table 106 Point of Care Molecular Diagnostics Market for Hospital-Acquired Infections, by Region, 2023-2030 (USD Million)
Table 107 North America: Point of Care Molecular Diagnostics Market for Hospital-Acquired Infections, by Country, 2023-2030 (USD Million)
Table 108 Europe: Point of Care Molecular Diagnostics Market for Hospital-Acquired Infections, by Country, 2023-2030 (USD Million)
Table 109 Asia-Pacific: Point of Care Molecular Diagnostics Market for Hospital-Acquired Infections, by Country, 2023-2030 (USD Million)
Table 110 Latin America: Point of Care Molecular Diagnostics Market for Hospital-Acquired Infections, by Country, 2023-2030 (USD Million)
Table 111 Middle East & Africa: Point of Care Molecular Diagnostics Market for Hospital-Acquired Infections, by Country, 2023-2030 (USD Million)
Table 112 Point of Care Molecular Diagnostics Market for Cancer, by Region, 2023-2030 (USD Million)
Table 113 North America: Point of Care Molecular Diagnostics Market for Cancer, by Country, 2023-2030 (USD Million)
Table 114 Europe: Point of Care Molecular Diagnostics Market for Cancer, by Country, 2023-2030 (USD Million)
Table 115 Asia-Pacific: Point of Care Molecular Diagnostics Market for Cancer, by Country, 2023-2030 (USD Million)
Table 116 Latin America: Point of Care Molecular Diagnostics Market for Cancer, by Country, 2023-2030 (USD Million)
Table 117 Middle East & Africa: Point of Care Molecular Diagnostics Market for Cancer, by Country, 2023-2030 (USD Million)
Table 118 Key Poc Molecular Diagnostic Products for Hepatitis Currently Available
Table 119 Point of Care Molecular Diagnostics Market for Hepatitis, by Region, 2023-2030 (USD Million)
Table 120 North America: Point of Care Molecular Diagnostics Market for Hepatitis, by Country, 2023-2030 (USD Million)
Table 121 Europe: Point of Care Molecular Diagnostics Market for Hepatitis, by Country, 2023-2030 (USD Million)
Table 122 Asia-Pacific: Point of Care Molecular Diagnostics Market for Hepatitis, by Country, 2023-2030 (USD Million)
Table 123 Latin America: Point of Care Molecular Diagnostics Market for Hepatitis, by Country, 2023-2030 (USD Million)
Table 124 Middle East & Africa: Point of Care Molecular Diagnostics Market for Hepatitis, by Country, 2023-2030 (USD Million)
Table 125 Key Poc Molecular Diagnostic Products for Gastrointestinal Disorders Currently Available
Table 126 Point of Care Molecular Diagnostics Market for Gastrointestinal Disorders, by Region, 2023-2030 (USD Million)
Table 127 North America: Point of Care Molecular Diagnostics Market for Gastrointestinal Disorders, by Country, 2023-2030 (USD Million)
Table 128 Europe: Point of Care Molecular Diagnostics Market for Gastrointestinal Disorders, by Country, 2023-2030 (USD Million)
Table 129 Asia-Pacific: Point of Care Molecular Diagnostics Market for Gastrointestinal Disorders, by Country, 2023-2030 (USD Million)
Table 130 Latin America: Point of Care Molecular Diagnostics Market for Gastrointestinal Disorders, by Country, 2023-2030 (USD Million)
Table 131 Middle East & Africa: Point of Care Molecular Diagnostics Market for Gastrointestinal Disorders, by Country, 2023-2030 (USD Million)
Table 132 Key Poc Molecular Diagnostic Products for Other Applications Currently Available
Table 133 Point of Care Molecular Diagnostics Market for Other Applications, by Region, 2023-2030 (USD Million)
Table 134 North America: Point of Care Molecular Diagnostics Market for Other Applications, by Country, 2023-2030 (USD Million)
Table 135 Europe: Point of Care Molecular Diagnostics Market for Other Applications, by Country, 2023-2030 (USD Million)
Table 136 Asia-Pacific: Point of Care Molecular Diagnostics Market for Other Applications, by Country, 2023-2030 (USD Million)
Table 137 Latin America: Point of Care Molecular Diagnostics Market for Other Applications, by Country, 2023-2030 (USD Million)
Table 138 Middle East & Africa: Point of Care Molecular Diagnostics Market for Other Applications, by Country, 2023-2030 (USD Million)
Table 139 Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 140 Point of Care Molecular Diagnostics Market for Hospitals, by Region, 2023-2030 (USD Million)
Table 141 Point of Care Molecular Diagnostics Market for Hospitals, by Disease Type, 2023-2030 (USD Million)
Table 142 North America: Point of Care Molecular Diagnostics Market for Hospitals, by Country, 2023-2030 (USD Million)
Table 143 Europe: Point of Care Molecular Diagnostics Market for Hospitals, by Country, 2023-2030 (USD Million)
Table 144 Asia-Pacific: Point of Care Molecular Diagnostics Market for Hospitals, by Country, 2023-2030 (USD Million)
Table 145 Latin America: Point of Care Molecular Diagnostics Market for Hospitals, by Country, 2023-2030 (USD Million)
Table 146 Middle East & Africa: Point of Care Molecular Diagnostics Market for Hospitals, by Country, 2023-2030 (USD Million)
Table 147 Point of Care Molecular Diagnostics Market for Physicians’ Offices/Clinics, by Region, 2023-2030 (USD Million)
Table 148 North America: Point of Care Molecular Diagnostics Market for Physicians’ Offices/Clinics, by Country, 2023-2030 (USD Million)
Table 149 Europe: Point of Care Molecular Diagnostics Market for Physicians’ Offices/Clinics, by Country, 2023-2030 (USD Million)
Table 150 Asia-Pacific: Point of Care Molecular Diagnostics Market for Physicians’ Offices/Clinics, by Country, 2023-2030 (USD Million)
Table 151 Latin America: Point of Care Molecular Diagnostics Market for Physicians’ Offices/Clinics, by Country, 2023-2030 (USD Million)
Table 152 Middle East & Africa: Point of Care Molecular Diagnostics Market for Physicians’ Offices/Clinics, by Country, 2023-2030 (USD Million)
Table 153 Point of Care Molecular Diagnostics Market for Research Institutes, by Region, 2023-2030 (USD Million)
Table 154 North America: Point of Care Molecular Diagnostics Market for Research Institutes, by Country, 2023-2030 (USD Million)
Table 155 Europe: Point of Care Molecular Diagnostics Market for Research Institutes, by Country, 2023-2030 (USD Million)
Table 156 Asia-Pacific: Point of Care Molecular Diagnostics Market for Research Institutes, by Country, 2023-2030 (USD Million)
Table 157 Latin America: Point of Care Molecular Diagnostics Market for Research Institutes, by Country, 2023-2030 (USD Million)
Table 158 Middle East & Africa: Point of Care Molecular Diagnostics Market for Research Institutes, by Country, 2023-2030 (USD Million)
Table 159 Point of Care Molecular Diagnostics Market for Other End-users, by Region, 2023-2030 (USD Million)
Table 160 North America: Point of Care Molecular Diagnostics Market for Other End-users, by Country, 2023-2030 (USD Million)
Table 161 Europe: Point of Care Molecular Diagnostics Market for Other End-users, by Country, 2023-2030 (USD Million)
Table 162 Asia-Pacific: Point of Care Molecular Diagnostics Market for Other End-users, by Country, 2023-2030 (USD Million)
Table 163 Latin America: Point of Care Molecular Diagnostics Market for Other End-users, by Country, 2023-2030 (USD Million)
Table 164 Middle East & Africa: Point of Care Molecular Diagnostics Market for Other End-users, by Country, 2023-2030 (USD Million)
Table 165 Point of Care Molecular Diagnostics Market, by Region, 2023-2030 (USD Million)
Table 166 North America: Macroeconomic Indicators
Table 167 North America: Point of Care Molecular Diagnostics Market, by Country, 2023-2030 (USD Million)
Table 168 North America: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 169 North America: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 170 North America: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 171 North America: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 172 North America: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 173 US: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 174 US: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 175 US: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 176 US: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 177 US: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 178 Canada: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 179 Canada: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 180 Canada: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 181 Canada: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 182 Canada: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 183 Europe: Macroeconomic Indicators
Table 184 Europe: Point of Care Molecular Diagnostics Market, by Country, 2023-2030 (USD Million)
Table 185 Europe: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 186 Europe: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 187 Europe: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 188 Europe: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 189 Europe: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 190 Germany: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 191 Germany: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 192 Germany: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 193 Germany: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 194 Germany: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 195 UK: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 196 UK: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 197 UK: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 198 UK: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 199 UK: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 200 France: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 201 France: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 202 France: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 203 France: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 204 France: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 205 Italy: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 206 Italy: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 207 Italy: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 208 Italy: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 209 Italy: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 210 Spain: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 211 Spain: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 212 Spain: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 213 Spain: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 214 Spain: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 215 Rest of Europe: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 216 Rest of Europe: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 217 Rest of Europe: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 218 Rest of Europe: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 219 Rest of Europe: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 220 Asia-Pacific: Macroeconomic Indicators
Table 221 Asia-Pacific: Point of Care Molecular Diagnostics Market, by Country, 2023-2030 (USD Million)
Table 222 Asia-Pacific: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 223 Asia-Pacific: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 224 Asia-Pacific: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 225 Asia-Pacific: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 226 Asia-Pacific: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 227 China: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 228 China: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 229 China: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 230 China: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 231 China: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 232 Japan: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 233 Japan: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 234 Japan: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 235 Japan: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 236 Japan: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 237 India: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 238 India: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 239 India: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 240 India: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 241 India: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 242 Rest of Asia-Pacific: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 243 Rest of Asia-Pacific: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 244 Rest of Asia-Pacific: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 245 Rest of Asia-Pacific: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 246 Rest of Asia-Pacific: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 247 Latin America: Macroeconomic Indicators
Table 248 Latin America: Point of Care Molecular Diagnostics Market, by Country, 2023-2030 (USD Million)
Table 249 Latin America: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 250 Latin America: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 251 Latin America: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 252 Latin America: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 253 Latin America: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 254 Brazil: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 255 Brazil: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 256 Brazil: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 257 Brazil: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 258 Brazil: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 259 Mexico: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 260 Mexico: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 261 Mexico: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 262 Mexico: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 263 Mexico: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 264 Rest of Latin America: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 265 Rest of Latin America: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 266 Rest of Latin America: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 267 Rest of Latin America: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 268 Rest of Latin America: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 269 Middle East & Africa: Macroeconomic Indicators
Table 270 Middle East & Africa: Point of Care Molecular Diagnostics Market, by Country, 2023-2030 (USD Million)
Table 271 Middle East & Africa: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 272 Middle East & Africa: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 273 Middle East & Africa: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 274 Middle East & Africa: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 275 Middle East & Africa: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 276 Kingdom of Saudi Arabia: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 277 Kingdom of Saudi Arabia: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 278 Kingdom of Saudi Arabia: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 279 Kingdom of Saudi Arabia: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 280 Kingdom of Saudi Arabia: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 281 United Arab Emirates: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 282 United Arab Emirates: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 283 United Arab Emirates: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 284 United Arab Emirates: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 285 United Arab Emirates: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 286 Rest of Middle East & Africa: Point of Care Molecular Diagnostics Market, by Product & Service, 2023-2030 (USD Million)
Table 287 Rest of Middle East & Africa: Point of Care Molecular Diagnostics Market, by Technology, 2023-2030 (USD Million)
Table 288 Rest of Middle East & Africa: Point of Care Molecular Diagnostics Market, by Sample Type, 2023-2030 (USD Million)
Table 289 Rest of Middle East & Africa: Point of Care Molecular Diagnostics Market, by Application, 2023-2030 (USD Million)
Table 290 Rest of Middle East & Africa: Point of Care Molecular Diagnostics Market, by End-user, 2023-2030 (USD Million)
Table 291 Overview of Strategies Deployed by Key Companies in Point of Care Molecular Diagnostics Market, January 2021-July 2025
Table 292 Point of Care Molecular Diagnostics Market: Degree of Competition
Table 293 Point of Care Molecular Diagnostics Market: Region Footprint
Table 294 Point of Care Molecular Diagnostics Market: Product & Service Footprint
Table 295 Point of Care Molecular Diagnostics Market: Technology Footprint
Table 296 Point of Care Molecular Diagnostics Market: Application Footprint
Table 297 Point of Care Molecular Diagnostics Market: Detailed List of Key Startups/SMEs
Table 298 Point of Care Molecular Diagnostics Market: Competitive Benchmarking of Key Emerging Players/Startups (1/2)
Table 299 Point of Care Molecular Diagnostics Market: Competitive Benchmarking of Startups/SMEs (2/2)
Table 300 Point of Care Molecular Diagnostics Market: Product/Service Launches & Approvals, January 2021-July 2025
Table 301 Point of Care Molecular Diagnostics Market: Deals, January 2021-July 2025
Table 302 Point of Care Molecular Diagnostics Market: Expansions, January 2021-July 2025
Table 303 Danaher Corporation: Company Overview
Table 304 Danaher Corporation: Products/Services Offered
Table 305 Danaher Corporation: Product/Service Launches & Approvals, January 2021-July 2025
Table 306 Danaher Corporation: Deals, January 2021-July 2025
Table 307 Danaher Corporation: Expansions, January 2021-July 2025
Table 308 Biomérieux: Company Overview
Table 309 Biomérieux: Products/Services Offered
Table 310 Biomérieux: Product/Service Approvals, January 2021-July 2025
Table 311 Biomérieux: Deals, January 2021-July 2025
Table 312 F. Hoffmann-La Roche Ltd.: Company Overview
Table 313 F. Hoffmann-La Roche Ltd.: Products/Services Offered
Table 314 F. Hoffmann-La Roche Ltd.: Products/Services Launches & Approvals, January 2021-July 2025
Table 315 F. Hoffmann-La Roche Ltd.: Deals, January 2021-July 2025
Table 316 F. Hoffmann-La Roche Ltd.: Expansions, January 2021-July 2025
Table 317 Abbott: Company Overview
Table 318 Abbott Products/Services Offered
Table 319 Abbott: Deals, January 2021-July 2025
Table 320 Qiagen N.V.: Company Overview
Table 321 Qiagen N.V.: Products/Services Offered
Table 322 Qiagen N.V.: Product Launches & Approvals, January 2021-July 2025
Table 323 Qiagen N.V.: Deals, January 2021-July 2025
Table 324 Qiagen N.V.: Expansions, January 2021-July 2025
Table 325 Quidelortho Corporation: Company Overview
Table 326 Quidelortho Corporation: Products/Services Offered
Table 327 Quidelortho Corporation: Product/Service Launches & Approvals, January 2021-July 2025
Table 328 Quidelortho Corporation: Deals, January 2021-July 2025
Table 329 Quidelortho Corporation: Expansions, January 2021-July 2025
Table 330 Co-Diagnostics, Inc.: Company Overview
Table 331 Co-Diagnostics, Inc.: Products/Services Offered
Table 332 Co-Diagnostics, Inc.: Deals, January 2021-July 2025
Table 333 Co-Diagnostics, Inc.: Expansions, January 2021-July 2025
Table 334 Biocartis: Company Overview
Table 335 Biocartis: Products/Services Offered
Table 336 Biocartis: Product/Service Launches & Approvals, January 2021-July 2025
Table 337 Biocartis: Deals, January 2021-July 2025
Table 338 Sd Biosensor, Inc.: Business Overview
Table 339 Sd Biosensor, Inc.: Products/Services Offered
Table 340 Sd Biosensor, Inc.: Product/Service Launches, January 2021-July 2025
Table 341 Sd Biosensor, Inc.: Deals, January 2021-July 2025
Table 342 Sd Biosensor, Inc.: Other Developments, January 2021-July 2025
Table 343 Genedrive PLC: Company Overview
Table 344 Genedrive PLC: Products/Services Offered
Table 345 Binx Health, Inc.: Company Overview
Table 346 Molbio Diagnostics Limited: Company Overview
Table 347 Opgen, Inc.: Company Overview
Table 348 Genomadix: Company Overview
Table 349 Visby Medical, Inc.: Company Overview
Table 350 Quantumdx Group Ltd.: Company Overview
Table 351 Detectachem: Company Overview
Table 352 Labsystems Diagnostics Oy: Company Overview
Table 353 Akonni Biosystems, Inc.: Company Overview
Table 354 Ubiquitome Limited: Company Overview
Table 355 Credo Diagnostics Biomedical Pte. Ltd.: Company Overview
Table 356 Nuclein, LLC: Company Overview
Table 357 Genes2Me: Company Overview
Table 358 Axxin: Company Overview
Table 359 Huwel Lifesciences: Company Overview

Figure 1 Point of Care Molecular Diagnostics Market Segmentation & Regional Scope
Figure 2 Years Considered
Figure 3 Point of Care Molecular Diagnostics Market: Research Design Methodology
Figure 4 Primary Sources
Figure 5 Breakdown of Primary Interviews: Supply Side and Demand Side Participants
Figure 6 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 7 Bottom-Up Approach: Company Revenue Estimation Approach
Figure 8 CAGR Projections: Supply-Side Analysis
Figure 9 Point of Care Molecular Diagnostics Market: Top-Down Approach
Figure 10 Data Triangulation Methodology
Figure 11 Point of Care Molecular Diagnostics Market: Research Assumptions
Figure 12 Point of Care Molecular Diagnostics Market, by Product & Service, 2025 vs. 2030 (USD Million)
Figure 13 Point of Care Molecular Diagnostics Market, by Technology, 2025 vs. 2030 (USD Million)
Figure 14 Point of Care Molecular Diagnostics Market, by Sample Type, 2025 vs. 2030 (USD Million)
Figure 15 Point of Care Molecular Diagnostics Market, by Application, 2025 vs. 2030 (USD Million)
Figure 16 Point of Care Molecular Diagnostics Market, by End-user, 2025 vs. 2030 (USD Million)
Figure 17 Point of Care Molecular Diagnostics Market, by Region, 2025 vs. 2030 (USD Million)
Figure 18 Increasing Advancements in Molecular Diagnostics Technologies to Propel Market
Figure 19 Assays & Kits Segment to Dominate Market During Forecast Period
Figure 20 Rt-Pcr Segment to Dominate Market During Forecast Period
Figure 21 Other Sample Types Segment to Dominate Market During Forecast Period
Figure 22 Respiratory Diseases Segment to Dominate Market During Forecast Period
Figure 23 Hospitals Segment to Dominate Market During Forecast Period
Figure 24 Asia-Pacific Region to Grow at Highest CAGR During Forecast Period
Figure 25 Point of Care Molecular Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 26 Patent Analysis for Point of Care Molecular Diagnostics (January 2014-December 2024)
Figure 27 Value Chain Analysis of Point of Care Molecular Diagnostics Market: Major Value Added During Manufacturing & Assembly Phases
Figure 28 Point of Care Molecular Diagnostics Market: Supply Chain Analysis
Figure 29 Point of Care Molecular Diagnostics Market: Ecosystem Analysis
Figure 30 Point of Care Molecular Diagnostics Market: Porter's Five Forces Analysis
Figure 31 Point of Care Molecular Diagnostics Market: Trends & Disruptions Impacting Customers’ Businesses
Figure 32 Influence of Stakeholders on Buying Process of Point of Care Molecular Diagnostic Products
Figure 33 Key Buying Criteria for Point of Care Molecular Diagnostic Products
Figure 34 Number of Deals & Funding Activities in Point of Care Molecular Diagnostics Market
Figure 35 Market Potential of AI in Point of Care Molecular Diagnostics Market
Figure 36 North America: Point of Care Molecular Diagnostics Market Snapshot
Figure 37 Asia-Pacific: Point of Care Molecular Diagnostics Market Snapshot
Figure 38 Revenue Analysis of Key Players in Point of Care Molecular Diagnostics Market, 2022-2024
Figure 39 Market Share Analysis of Key Players in Point of Care Molecular Diagnostics Market (2024)
Figure 40 Point of Care Molecular Diagnostics Market: Company Evaluation Matrix (Key Players), 2024
Figure 41 Point of Care Molecular Diagnostics Market: Company Footprint
Figure 42 Point of Care Molecular Diagnostics Market: Company Evaluation Matrix (Startups/SMEs), 2024
Figure 43 EV/EBITDA of Key Vendors
Figure 44 Year-To-Date (YTD) Price Total Return and 5-Year Stock Beta of Key Vendors
Figure 45 Point of Care Molecular Diagnostics Market: Brand Comparison for Instruments
Figure 46 Danaher Corporation: Company Snapshot (2024)
Figure 47 Biomérieux: Company Snapshot (2024)
Figure 48 F. Hoffmann-La Roche Ltd.: Company Snapshot (2024)
Figure 49 Abbott: Company Snapshot (2024)
Figure 50 Qiagen N.V.: Company Snapshot (2024)
Figure 51 Quidelortho Corporation: Company Snapshot (2024)
Figure 52 Co-Diagnostics, Inc.: Company Snapshot (2024)
Figure 53 Biocartis: Company Snapshot (2022)
Figure 54 Sd Biosensor, Inc.: Company Snapshot (2024)
Figure 55 Genedrive PLC: Company Snapshot (2024)